☆ 4.6 Article

Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a New Protocol for Investigating the Mechanisms of Idiopathic Pulmonary Fibrosis

CELLS (2022)

Related references

Note: Only part of the references are listed.

Article Respiratory System

The role of precision medicine in interstitial lung disease

Toby M. Maher et al.

Summary: The management of interstitial lung disease (ILD) can benefit from individualized treatment strategies that consider diagnostic classification and disease behavior. Biomarker-based approaches hold promise in precision medicine for ILD, with potential applications in staging, prognosis, and treatment response assessment. Artificial intelligence has the potential to redefine prognostic evaluation and improve individualized treatment algorithms.

EUROPEAN RESPIRATORY JOURNAL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT

Margherita Sisto et al.

Summary: Recent advances in understanding the molecular pathways linking inflammation with organ fibrosis and autoimmune diseases have identified EMT as a common association. The chronic inflammatory microenvironment plays a crucial role in inducing pathological EMT, with TGF-beta being a key player in fibrosis induction. Further research aims to target EMT-dependent fibrosis in autoimmune diseases through a better understanding of molecular responses to inflammatory signals.

BIOMOLECULES (2021)

Add to Collection

Article Pharmacology & Pharmacy

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases

Xianqiu Chen et al.

Summary: This study assessed clinical characteristics and outcomes of PF-ILD patients in a single-center cohort, finding that extent of fibrotic changes on HRCT and pulmonary hypertension were predictors of mortality in patients with PF-ILD.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases

Laura Bergantini et al.

Summary: The study applied the new Bronchoalveolar Cytology Threshold (BCT) index to the analysis of interstitial lung diseases (ILDs) for the first time, showing its potential for differential diagnosis. BAL cell patterns and the BCT index were found to provide useful information for distinguishing ILDs, reducing the need for invasive procedures. Integrated approaches to BAL analysis can improve the interpretation of results without additional cost or time.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Cell Biology

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach

Miriana d'Alessandro et al.

Summary: This multicenter study revealed significant differences in exosomal surface epitope expression between IPF patients and healthy controls. Higher levels of markers such as CD19, CD69, CD8, and CD86 were observed in IPF patients, while CD42a was lower. Survival analysis indicated potential predictive value of CD25 and CD8 expression levels in IPF patient outcomes.

CELLS (2021)

Add to Collection

Article Oncology

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

Colin Hutton et al.

Summary: This study used mass cytometry to analyze the stromal composition in murine tissues and tumors, revealing extensive stromal heterogeneity and coordinated relationships between mesenchymal and immune cell subsets in pancreatic ductal adenocarcinoma. The research identified two stable and functionally distinct pancreatic fibroblast lineages marked by CD105 expression, with CD105-positive fibroblasts promoting tumor growth and CD105-negative fibroblasts suppressing tumors, dependent on adaptive immunity. These findings highlight the importance of mesenchymal and immune cell interactions in restricting tumor growth.

CANCER CELL (2021)

Add to Collection

Article Immunology

Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases

Laura Bergantini et al.

Summary: This study analyzed the percentages of NK and NKT-like cells in BAL from patients with different ILD and found that the BAL NK cell percentages in IPF were significantly higher than in f-HP and f-NSIP, while NKT-like cells were significantly lower in f-NSIP than in f-HP and IPF. A cut-off value of 4% NK cells in BAL of IPF showed a significant difference in survival rate, suggesting a potential new marker for survival and raising the possibility of a new targeted approach in the treatment and management of IPF.

CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Immunologic responses to antifibrotic treatment in IPF patients

Miriana d'Alessandro et al.

Summary: The study revealed that nintedanib significantly improves immunological responses in IPF patients, especially in the reduction of various T cell subpopulations. Logistic regression analysis showed high accuracy of the Tfh panel in distinguishing between IPF and healthy controls.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis

Paolo Giannoni et al.

Summary: Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by inhalation of various antigens, while fibrotic HP (fHP) may be associated with idiopathic pulmonary fibrosis and have a worse prognosis. A fibroblastic cell line derived from a patient with fHP was established and characterized, showing features similar to myofibroblasts, and could potentially serve as a tool to model the disease in vitro. Preliminary assessment of pirfenidone demonstrated consistent inhibition of cell growth.

BIOMEDICINES (2021)

Add to Collection

Article Respiratory System

Tropomyosin 2.1 collaborates with fibronectin to promote TGF-β1-induced contraction of human lung fibroblasts

Peta Bradbury et al.

Summary: Many lung diseases are characterized by fibrosis, which is driven by the two-way interaction between cells and the extra-cellular matrix. The inflammatory cytokine growth factor beta(1) is believed to be a major driver of lung fibrosis.

RESPIRATORY RESEARCH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis

Elena Bargagli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Physiology

New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis

Lili Sheng et al.

FRONTIERS IN PHYSIOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study

Paolo Cameli et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Mechanical and Physical Regulation of Fibroblast-Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology

Mirko D'Urso et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Add to Collection

Editorial Material Oncology

Identification, Friend or Foe: Vimentin and α-Smooth Muscle Actin in Cancer-Associated Fibroblasts

Sachiyo Nomura

ANNALS OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Cell Biology

TGF-β1 Signaling and Tissue Fibrosis

Kevin K. Kim et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Add to Collection

Article Oncology

Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation

Hyun Young Koo et al.

JOURNAL OF PATHOLOGY (2018)

Add to Collection

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Review Respiratory System

Idiopathic pulmonary fibrosis: pathogenesis and management

Giacomo Sgalla et al.

RESPIRATORY RESEARCH (2018)

Add to Collection

Review Medicine, General & Internal

Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis

Jun Tashiro et al.

FRONTIERS IN MEDICINE (2017)

Add to Collection

Article Hematology

Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable

Ryan A. Denu et al.

ACTA HAEMATOLOGICA (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Lung extracellular matrix and redox regulation

Walter H. Watson et al.

REDOX BIOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Fibroblast Growth Factor 2 Is Required for Epithelial Recovery, but Not for Pulmonary Fibrosis, in Response to Bleomycin

Robert D. Guzy et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Vimentin regulates activation of the NLRP3 inflammasome

Gimena dos Santos et al.

NATURE COMMUNICATIONS (2015)

Add to Collection

Review Pharmacology & Pharmacy

Fibroblasts in fibrosis: novel roles and mediators

Ryan T. Kendall et al.

FRONTIERS IN PHARMACOLOGY (2014)

Add to Collection

Article Critical Care Medicine

An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

Keith C. Meyer et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)

Add to Collection

Article Biochemistry & Molecular Biology

TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway

Li Xiao et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2012)

Add to Collection

Article Respiratory System

Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?

K. C. Meyer et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Add to Collection

Article Respiratory System

Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance

C. Quesnel et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Add to Collection

Article Multidisciplinary Sciences

Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis

Marialuisa Bocchino et al.

PLOS ONE (2010)

Add to Collection

Article Pathology

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-ß1 -: Potential role in idiopathic pulmonary fibrosis

BC Willis et al.

AMERICAN JOURNAL OF PATHOLOGY (2005)

Add to Collection

Article Cell Biology

CD105 prevents apoptosis in hypoxic endothelial cells

CG Li et al.

JOURNAL OF CELL SCIENCE (2003)

Add to Collection

Article Oncology

Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies

E. Fonsatti et al.

CURRENT CANCER DRUG TARGETS (2003)

Add to Collection

Review Respiratory System

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder

M Selman et al.

RESPIRATORY RESEARCH (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.